NovaQuest provides structured finance for Phase III pharma partners
The influx of PE investment in drug development is 'great evidence of the need for capital solutions for the life sciences,' said NovaQuest’s Patrick Jordan.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
